Erectile dysfunction serves as an early clinical manifestation of systemic vascular disease, frequently preceding the onset of cardiovascular disease by two to five years.
Erectile dysfunction should be treated as an early clinical manifestation of systemic vascular disease, prompting comprehensive cardiovascular risk assessment and preventive interventions.
Erectile dysfunction (ED) has evolved from a quality-of-life concern to a recognized marker of systemic vascular disease and an early harbinger of cardiovascular events. The Princeton IV Consensus underscores that men presenting with erectile dysfunction should be presumed at increased cardiovascular risk until proven otherwise, advocating integrated risk stratification and lifestyle optimization. Beyond established risk scores, advances in omics, vascular imaging, and digital health promise precision tools for early detection and prevention. This review aims to examine erectile dysfunction as an early marker of cardiovascular disease and to summarize current and emerging approaches to cardiovascular risk stratification in men with ED.
Lozoya et al. (Thu,) conducted a review in Erectile dysfunction and cardiovascular disease. Cardiovascular risk stratification was evaluated. Erectile dysfunction serves as an early clinical manifestation of systemic vascular disease, frequently preceding the onset of cardiovascular disease by two to five years.